182 related articles for article (PubMed ID: 10520424)
1. [Multiple primary breast cancer].
Volchenko NN
Arkh Patol; 1999; 61(4):21-5. PubMed ID: 10520424
[TBL] [Abstract][Full Text] [Related]
2. [Tubular carcinoma of the breast (clinico-morphological characteristics)].
Frank GA; Volchenko NN
Vopr Onkol; 1985; 31(5):15-21. PubMed ID: 2990106
[TBL] [Abstract][Full Text] [Related]
3. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
4. [Bilateral carcinoma of the breast].
Napolitano L; Grossi S; Cianchetti E
Ann Ital Chir; 1993; 64(6):665-8; discussion 668-9. PubMed ID: 8080156
[TBL] [Abstract][Full Text] [Related]
5. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
6. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
Bollet MA; Servant N; Neuvial P; Decraene C; Lebigot I; Meyniel JP; De Rycke Y; Savignoni A; Rigaill G; Hupé P; Fourquet A; Sigal-Zafrani B; Barillot E; Thiery JP
J Natl Cancer Inst; 2008 Jan; 100(1):48-58. PubMed ID: 18159071
[TBL] [Abstract][Full Text] [Related]
7. [Recurrence after surgery of breast cancer or a secondary disease?].
Wöhlke G; Möbius G
Pathologe; 1989 Mar; 10(2):93-6. PubMed ID: 2541425
[No Abstract] [Full Text] [Related]
8. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
[TBL] [Abstract][Full Text] [Related]
9. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma.
Crombie N; Rampaul RS; Pinder SE; Elston CW; Robertson JF; Ellis IO
Br J Surg; 2001 Oct; 88(10):1324-9. PubMed ID: 11578285
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
Dauplat MM; Penault-Llorca F
Ann Pathol; 2009 Jun; 29(3):228-32. PubMed ID: 19619831
[No Abstract] [Full Text] [Related]
11. Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast-a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours.
Idvall I; Ringberg A; Anderson H; Akerman M; Fernö M
Breast; 2005 Aug; 14(4):290-7. PubMed ID: 16085235
[TBL] [Abstract][Full Text] [Related]
12. The pathology of lumpectomy with particular reference to local breast recurrence and multicentricity.
Fisher ER
Verh Dtsch Ges Pathol; 1985; 69():51-61. PubMed ID: 4096122
[No Abstract] [Full Text] [Related]
13. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
14. Management of bilateral breast carcinoma: long-term results.
Goksel HA; Yagmurdur MC; Karakayali H; Moray G; Demirhan B; Isiklar I; Bilgin N; Haberal M
Int Surg; 2004; 89(3):166-71. PubMed ID: 15521255
[TBL] [Abstract][Full Text] [Related]
15. Contralateral breast cancer: factors associated with stage and size at presentation.
Mertens WC; Hilbert V; Makari-Judson G
Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
[TBL] [Abstract][Full Text] [Related]
16. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
17. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
[TBL] [Abstract][Full Text] [Related]
18. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
19. [Lobular carcinoma in situ of the breast].
Chapron C; Laurent JC; Vilain MO; Giard S
Rev Fr Gynecol Obstet; 1990 Mar; 85(3):174-81. PubMed ID: 2185530
[TBL] [Abstract][Full Text] [Related]
20. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
